222
Participants
Start Date
April 30, 2012
Primary Completion Date
July 31, 2015
Study Completion Date
July 31, 2016
TG4010
"TG4010 • TG4010 will be administered starting on Day 1 (D1) of Cycle 1 of chemotherapy and will be administered weekly for 6 weeks by subcutaneous (SC) injections and then once every 3 weeks until progression or discontinuation due to any reason.~Chemotherapy (and bevacizumab if prescribed), will be given as 21-day cycles for a minimum of 4 cycles and up to 6 cycles.~First line therapy:~* Non-squamous carcinoma: pemetrexed + cisplatin or paclitaxel + carboplatin +/- bevacizumab~* Squamous carcinoma: gemcitabine + cisplatin or paclitaxel + carboplatin~Maintenance therapy:~• Pemetrexed or erlotinib for eligible patients and according to labeling."
placebo
"Placebo will be administered starting on D1 of Cycle 1 of chemotherapy and will be administered weekly for 6 weeks by SC injections and then once every 3 weeks until progression or discontinuation due to any reason.~* First line therapy: as in Arm 1~* Maintenance therapy: as in Arm 1"
Orszagos Onkologiai Intezet, Budapest
Semmelweis Egyetem AOK, Budapest
Orszagos Koranyi TBC es Pulmonologiai Intezet, Budapest
ZNA Middelheim, Antwerp
Tudogyogyintezet Torokbalint, Törökbálint
Massachusetts General Hospital, Cambridge
Komarom-Esztergom Megyei Onkorm. Szent Borbala Korhaza, Tatabánya
Matrai Gyogyintezet, Mátraháza
C. H. U. Sart-Tilman, Liège
Kenezy Korhaz-Rendelointezet Eu Szolgaltato Nonprofit Kft, Debrecen
Bekes Megyei Kepviselotestulet Pandy Kalman Korhaza, Gyula
Clinique Nôtre-Dame de Grâce, Gosselies
Azienda Ospedaliera di Perugia Ospedale S.Maria della Miseri, Perugia
Centre Hospitalier de l'Ardenne, Libramont
Tolna Megyei Onkormanyzat Balassa Janos Korhaza, Szekszárd
Fejér Megyei Szent György Kórház, Székesfehérvár
Zala Megyei Korhaz, Zalaegerszeg
Petz Aladár Megyei Oktató kórház, Győr
Institut Paoli-Calmettes, Service d'oncologie médicale, Marseille
Hospital Universitario Reina Sofia, Córdoba
Centre François Baclesse, Caen
ICO Girona - Hospital Dr Josep Trueta, Girona
Abington Hematology Oncology Associates Inc, Willow Grove
IEO Istituto Europeo di Oncologia, Milan
Universitaetsklinikum Hamburg-Eppendorf, Hamburg
Oncology/Hematology P.C., Rockville
Centre Médical Alfred Leune, Sainte-Feyre
CHU, Service de Pneumologie, Besançon
Hospital Gregorio Marañon, Madrid
START Madrid. Centro Integral Oncologico Clara Campal, Madrid
Hospital General Carlos Haya, Málaga
Hôpital Pontchaillou, Rennes
University of Louisville Hospital, Louisville
CHU de Saint-Etienne, Hôpital Nord, Saint-Etienne
Institut de Cancérologie Lucien Neuwirth, Saint-Priest-en-Jarez
ProMedica Health System Inc, Toledo
Chaim Sheba Medical Center, Ramat Gan
Signal Point Clinical Research Center, Middletown
Rabin Medical Center-Beilinson Campus, Petah Tikva
Sapir Medical Center Meir Hospital, Kfar Saba
A.O.U. Senese Policlinico Santa Maria alle Scotte, Siena
CHRU de Lille Hopital Calmette, Lille
Szpital Kliniczny Przemienienia Panskiego Uniwersytetu Medycznego im. Karola Marcinkowskiego, Poznan
CHU de Clermont-Ferrand, Hopital Gabriel Montpied, Clermont-Ferrand
Washington University, St Louis
Tel Aviv Sourasky Medical Center, Tel Aviv
Cotton O'Neil Clinical Research Center, Topeka
Nouvel Hôpital Civil, Strasbourg
Hôpital Pasteur - Service de médecine F- Pavillon 43, Colmar
CH Mulhouse Hopital Emile Muller Moenchsberg, Mulhouse
Universitaetsklinikum Mannheim, Mannheim
Centre Hospitalier Intercommunal de la Haute Saone, Vesoul
Assaf Harofeh Medical Center, Beer Yaacov
Highlands Oncology Group, Fayetteville
Hopital Saint Joseph, Paris
Mary Crowley Medical Research Center, Dallas
Kaplan Medical Center, Rehovot
Texas Oncology, P.A. - Abilene (South), Abilene
Mayo Clinic Arizona, Scottsdale
Clinique François Chénieux, Limoges
Hadassah Ein Kerem Medical Center, Jerusalem
Centre Hospitalier Intercommunal de Créteil, Créteil
Samodzielny Publiczny Szpital Kliniczny nr 4 w Lublinie, Lublin
SP Zespol Gruzlicy i Chorob Pluc w Olsztynie, Olsztyn
Mazowieckie Centrum Leczenia Chorob Pluc i Gruzlicy, Otwock
Centrum Onkologii-Instytut im. M. Sklodowskiej Curie, Warsaw
Hospital Universitari Vall d'Hebron, Barcelona
Corporació Sanitària Parc Taulí, Sabadell
Queen Elizabeth Hospital, Birmingham
Velindre Hospital NHS Trust, Cardiff
Plymouth Oncology Centre, Plymouth
Southampton University Hospitals NHS Trust, Southampton
Lead Sponsor
Transgene
INDUSTRY